|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.040 EUR | 0.00% |
|
+0.50% | +9.19% |
| 05-05 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-04 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
| Market Cap | 192M 219M 177M 163M 310M 20.92B 315M 2.11B 831M 10.31B 824M 806M 35.44B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 192M 219M 177M 163M 310M 20.92B 315M 2.11B 831M 10.31B 824M 806M 35.44B | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.24x |
| Free-Float |
12.27% | Yield 2026 * |
0.99% | Yield 2027 * | 0.99% |
| 1 week | +0.50% | ||
| Current month | +2.02% | ||
| 1 month | +1.51% | ||
| 3 months | +14.12% | ||
| 6 months | +8.60% | ||
| Current year | +9.19% |
| 1 week | 3.92 |  | 4.1 |
| 1 month | 3.9 | | 4.18 |
| Current year | 3.22 | | 4.26 |
| 1 year | 2.86 | | 4.26 |
| 3 years | 2.28 | | 4.26 |
| 5 years | 2.28 | | 4.26 |
| 10 years | 2.28 | | 6.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 49 | - |
Martin Buse
CMP | Compliance Officer | - | - |
Thomas Piefke
COO | Chief Operating Officer | - | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 31/12/2002 |
Michael Bock
BRD | Director/Board Member | 63 | 24/05/2005 |
| Director/Board Member | 63 | 19/09/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +0.50% | +36.49% | +33.77% | 219M | |
| +1.44% | +3.56% | +28.27% | +43.54% | 18.32B | |
| -0.05% | -0.59% | +22.97% | +68.18% | 13.33B | |
| +2.08% | -2.34% | -33.25% | -55.11% | 11.41B | |
| -0.77% | +3.48% | -6.98% | +64.69% | 10.93B | |
| -0.20% | +0.22% | +17.09% | +87.99% | 9.77B | |
| +0.51% | -2.49% | -2.00% | -29.37% | 9.36B | |
| +1.74% | -0.68% | +26.61% | +191.48% | 7.66B | |
| +0.88% | +2.24% | -22.45% | - | 6.9B | |
| -2.31% | -5.00% | +10.72% | -24.52% | 6.71B | |
| Average | +0.33% | +0.17% | +7.75% | +42.29% | 9.46B | |
| Weighted average by Cap. | +0.50% | +0.55% | +6.82% | +41.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 900M 726M 671M 1.27B 85.86B 1.29B 8.68B 3.41B 42.3B 3.38B 3.31B 145B | 803M 918M 741M 684M 1.3B 87.58B 1.32B 8.85B 3.48B 43.15B 3.45B 3.37B 148B |
| Net income | 36.66M 41.91M 33.82M 31.23M 59.26M 4B 60.26M 404M 159M 1.97B 157M 154M 6.77B | 38.2M 43.67M 35.23M 32.54M 61.74M 4.16B 62.78M 421M 165M 2.05B 164M 160M 7.05B |
| Net Debt | - | - |
Employees
7,416
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | €4.040 | 0.00% | 32 |
| 09/07/26 | €4.040 | 0.00% | 4,492 |
| 08/07/26 | €4.040 | +0.50% | 2,402 |
| 07/07/26 | €4.020 | -0.99% | 2,170 |
| 06/07/26 | €4.060 | +1.00% | 2,841 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.040EUR
Average target price
7.300EUR
Spread / Average Target
+80.69%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
